This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1087057107313763v1 13/2/128    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Wu, W. Articles by Li, J. Search for Related Content PubMed PubMed Citation Articles by Wu, W. Articles by Li, J. Social Bookmarking                         What's this?

Identification of Glucose-Dependant Insulin Secretion Targets in Pancreatic Cells by Combining Defined-Mechanism Compound Library Screening and siRNA Gene Silencing

Merck & Co

^* To whom correspondence should be addressed. E-mail: jing_li4{at}merck.com.

	Abstract

Identification and validation of novel drug targets continues to be a major bottleneck in drug development, particularly for polygenic complex diseases such as type 2 diabetes. Here, the authors describe an approach that allows researchers to rapidly identify and validate potential drug targets by combining chemical tools and RNA interference technology. As a proof-of-concept study, the known mechanism Sigma LOPAC library was used to screen for glucose-dependent insulin secretion (GDIS) in INS-1 832/13 cells. In addition to several mechanisms that are known to regulate GDIS (such as cyclic adenosine monophosphate–specific phosphodiesterases, adrenoceptors, and Ca<Sup>2+</Sup> channels), the authors find that several of the dopamine receptor (DRD) antagonists significantly enhance GDIS, whereas DRD agonists profoundly inhibit GDIS. Subsequent siRNA studies in the same cell line indicate that knockdown of DRD2 enhanced GDIS. Furthermore, selective DRD2 antagonists and agonists also enhance or suppress, respectively, GDIS in isolated rat islets. The data support that the approach described here offers a rapid and effective way for target identification and validation. (Journal of Biomolecular Screening XXXX;xx-xx)

First published on January 23, 2008, doi:10.1177/1087057107313763

Journal of Biomolecular Screening 2008;13:128.

A more recent version of this article appeared on February 1, 2008


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?